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RESEARCH NOTE
Codon-optimized DsRed fluorescent 
protein for use in Mycobacterium tuberculosis
Paul Carroll1, Julian Muwanguzi‑Karugaba1 and Tanya Parish1,2* 
Abstract 
Objective: We have previously codon‑optimized a number of red fluorescent proteins for use in Mycobacterium 
tuberculosis (mCherry, tdTomato, Turbo‑635). We aimed to expand this repertoire to include DsRed, another widely 
used and flexible red fluorescent protein.
Results: We generated expression constructs with a full length DsRed under the control of one of three strong, 
constitutive promoters  (Phsp60,  PrpsA or  PG13) for use in mycobacteria. We confirmed that full length DsRed (225 amino 
acids) was expressed and fluoresced brightly. In contrast to mCherry, truncated versions of DsRed lacking several 
amino acids at the N‑terminus were not functional. Thus, we have expanded the repertoire of optimized fluorescent 
proteins for mycobacteria.
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Introduction
Fluorescent proteins (FPs) have become the work horses 
of molecular biology and microbiology, with numerous 
applications. A plethora of variants of Aequorea victoria 
green fluorescent protein (GFP) [1] and Discosoma sp 
red fluorescent protein (DsRed) [2] are available cover-
ing almost the whole light spectrum from green to infra-
red [3]. Mutant derivatives have been engineered with 
altered excitation and emission wavelengths, increased or 
decreased stability, resistance to photo bleaching, sensi-
tivity to environmental stimuli and substrates, as well as 
time for fluorophore maturation, intrinsic brightness and 
multimeric formats [3, 4]. We previously described the 
use of a range of red reporters, of which the brightest was 
mCherry [5]. We wanted to expand our repertoire of pro-
teins. Since DsRed has been widely used as a bright and 
stable reporter, we optimized constructs for its expres-
sion in M. tuberculosis.
Main text
Materials and methods
Bacterial culture
Escherichia coli DH5α was cultured in LB medium or on 
LA agar. M. tuberculosis H37Rv was grown in Middle-
brook 7H9 medium plus 10% v/v OADC (oleic acid, albu-
men, dextrose, catalase) supplement (Becton–Dickinson) 
and 0.05% w/v Tween 80 or on Middlebrook 7H10 agar 
(Becton–Dickinson) plus 10% v/v OADC. Hygromycin 
was used at 100 μg/ml where required.
Construction of expression vectors
The DsRed expression vectors were constructed as 
follows: a partial DsRed sequence was codon opti-
mized for M. tuberculosis, synthesised and cloned into 
pUC57 (Genscript USA Inc.) to generate pRed1. The 
DsRed ORF was excised from pUC57 as a BamHI/Hin-
dIII fragment and cloned into pSMT3 [6] to generate 
pBlaze1. The DsRed ORF was extended three times by 
PCR to generate pRedA1, pRedB1 and pRedC1 using 
primers DsRed-F1 5′-GGA TCC ATG CGC TTC AAG 
GTG CGC ATG GAG GGC TCG GTG AAC-3′, DsRed-
F2 5′-GGA TCC GAC GTG ATC AAG GAG TTC ATG 
CGC TTC AAG GTG CGC-3′ and DsRed-F3 5′-GGA 
TCC ATG GCC TCG TCG GAG GAC GTG ATC AAG 
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GAG TTC together with the reverse primer DsRed-R 
5′-AAG CTT TTA CAG GAA CAG GTG GTG CCG-
3′. The restriction sites are underlined, potential start 
codons are in bold. The ORFs were excised and cloned 
into pSMT3 [6] as BamHI/HindIII fragments to gen-
erate pBlazeA1, pBlazeB1 and pBlazeC1 with DsRed 
under the control of the hsp60 promoter (Table  1). 
Plasmids pBlazeC8 and pBlazeC10 were generated by 
replacing  Phsp60 with  PrpsA and  PG13 respectively. All 
three promoters should drive constitutive high level 
expression [5, 7, 8].
Quantitation of fluorescence in whole cells
Mycobacterium tuberculosis was electroporated as 
described [9] and transformants selected with hygro-
mycin. M. tuberculosis was grown to stationary phase, 
harvested, washed twice in 10  mM Tris pH 8.0 and 
resuspended in 10  mM Tris pH 8.0 to an  OD580 of 
0.25, 0.10, 0.05 and 0.01 in 12 × 100  mm glass culture 
tubes. Fluorescence was measured on a Shimadzu 
RF-1501 spectrofluorimeter (Shimadzu) with a detec-
tion range of 0–1015 relative fluorescent units at Ex/
Em 558/583 nm [5].
Western analysis of fluorescent proteins
Cell extracts were prepared from liquid cultures. Cells 
were harvested by centrifugation, washed twice in 
10 mM Tris (pH 8.0), resuspended in 1 ml of 10 mM 
Tris (pH 8.0), and added to lysing matrix B tubes 
(QBiogene). Cells were disrupted using the Fastprep 
(QBiogene) set at speed 6.0 for 30  s. Samples were 
centrifuged at 4000  rpm for two min, and the super-
natant was recovered and filter sterilized (0.2 micron 
filter). Protein was quantified using a BCA kit (Pierce), 
and 10 μg of total protein was subjected to Western 
blot using a rabbit anti-body (Clonetech). The primary 
antibody was detected using horseradish peroxidase 
goat-anti-rabbit (Sigma), and activity was detected 
using an ECL kit (GE Healthcare).
Results
We were interested in the use of FPs in M. tuberculosis 
and had previously used these as reporters of bacterial 
viability for in  vitro and in  vivo studies [5, 8]. We were 
successful in obtaining high level expression by using 
codon-optimized versions of red fluorescent proteins 
driven by strong mycobacterial promoters [5].
Optimization of DsRed expression
We wanted to expand the range of reporters available for 
use to increase flexibility and allow dual reporter expres-
sion and monitoring. We selected DsRed for optimiza-
tion, based on its Ex/Em wavelengths, and the fact that it 
is a well-characterized FP in wide use [3, 4, 10–14].
Expression of DsRed uses a different translational start site 
than mCherry
Our initial attempts to obtain expression of a codon-
optimized DsRed were unsuccessful. We constructed 
a synthetic gene for DsRed using a similar approach as 
we used with another red fluorescent protein mCherry 
(Fig.  1). We designed a codon-optimized version based 
on the DsRed-T3 protein previously used. We cloned the 
synthetic version into a mycobacterial expression vector 
and tested for fluorescence in M. tuberculosis. Surpris-
ingly, we did not detect any fluorescence from this con-
struct (Fig. 1c).
mCherry is a variant of DsRed and we expected the 
two proteins would be similarly functional. Our previ-
ous work demonstrated that mCherry is expressed from 
a distal translational start site than the one annotated in 
the databases [15]. Sequence alignment shows the few 
mutations which differ between the two (Fig.  2a); these 
include loss of the translational start site we identified 
for mCherry, although there are still multiple transla-
tional start sites (Fig.  1a). The version we used for the 
Table 1 Plasmids used in this study
Plasmid Description Promoter Fluorescent protein Source
pSMT3 Shuttle vector,  Phsp60, HygR [6]
pRED1 Codon‑optimized DsRed in pUC57 None DsRed208 This study
pBlaze1 DsRed expression vector. HygR Hsp60 DsRed208 This study
pBlazeA1 DsRed expression vector. HygR Hsp60 DsRed214 This study
pBlazeB1 DsRed expression vector. HygR Hsp60 DsRed220 This study
pBlazeC1 DsRed expression vector. HygR Hsp60 DsRed225 This study
pBlazeC8 DsRed expression vector. HygR RpsA DsRed225 This study
pBlazeC10 DsRed expression vector. HygR G13 DsRed225 This study
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ATGGCCTCGTCGGAGGACGTGATCAAGGAGTTCATGCGCTTCAAGGTGCGCATGG
AGGGCTCGGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCC
GTACGAGGGCACCCAGACCGCCAAGCTGAAGGTCACCAAGGGCGGCCCGCTGCCG
TTCGCCTGGGACATCCTGTCGCCGCAGTTCCAGTACGGCAGCAAGGTGTACGTCA
AGCACCCGGCCGACATCCCGGACTACAAGAAGCTGAGCTTCCCGGAGGGCTTCAA
GTGGGAGCGGGTGATGAACTTCGAGGACGGCGGCGTGGTCACCGTCACCCAGGAC
TCGAGCCTGCAGGACGGCTGCTTCATCTACAAGGTGAAGTTCATCGGCGTCAACT
TCCCGAGCGACGGCCCGGTGATGCAGAAGAAGACCATGGGCTGGGAGCCGTCGAC
CGAGCGCCTGTACCCGCGGGACGGCGTGCTGAAGGGCGAGATCCACAAGGCCCTG
AAGCTGAAGGACGGCGGCCACTACCTGGTCGAGTTCAAGTCGATCTACATGGCGA
AGAAGCCGGTGCAGCTGCCGGGCTACTACTACGTCGACTCGAAGCTGGACATCAC
CAGCCACAACGAGGACTACACCATCGTCGAGCAGTACGAGCGCACCGAGGGCCGG
CACCACCTGTTCCTGTAA
MASSEDVIKEFMRFKVRMEGSVNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLP
FAWDILSPQFQYGSKVYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGVVTVTQD
SSLQDGCFIYKVKFIGVNFPSDGPVMQKKTMGWEPSTERLYPRDGVLKGEIHKAL
KLKDGGHYLVEFKSIYMAKKPVQLPGYYYVDSKLDITSHNEDYTIVEQYERTEGR
HHLFL
a
b
c
Fig. 1 Expression of non‑functional DsRed. a DsRed Protein sequence. Three potential translational start sites (methioinine) are indicated in bold. 
The valine which corresponds to the methionine start site of mCherry in M. tuberculosis is also indicated in bold. b DNA sequence of DsRed. The 
5′ end of the synthetic gene designed to codon‑optimize DsRed for M. tuberculosis is boxed. Potential starts sites are indicated in bold. The Shine 
Delgarno sequence is underlined. c M. tuberculosis was resuspended in 10 mM Tris pH 8.0 to an  OD580 of 0.25, 0.10, 0.05 and 0.01 in 12 × 100 mm 
glass culture tubes. Fluorescence was measured at Ex/Em 558/583 nm. WT—wild‑type (no plasmid). pBlaze1—recombinant strain carrying DsRed 
208aa. Data are the average ± SD of three cultures
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synthetic gene used a downstream translation start site 
and would produce a truncated version of DsRed as com-
pared to mCherry. Therefore it was possible that we did 
not express the full protein (Fig.  1b). In order to deter-
mine the functional start site for DsRed we used a differ-
ent approach in which we cloned several versions of the 
1 2 3 4 5 6 7 8 9
a
b
c
Fig. 2 Expression of functional DsRed. a Sequence alignment of mCherry and DsRed. Protein sequences were aligned using Clustal 2.1 [19]. b 
Activity of full length DsRed expressed from mycobacterial promoters. pBlazeC1‑Phsp60; pBlazeC8‑PrpsA; pBlazeC10‑PG13. Recombinant M. tuberculosis 
was resuspended in 10 mM Tris pH 8.0 to an  OD580 of 0.25, 0.10, 0.05 and 0.01 in 12 × 100 mm glass culture tubes. Fluorescence was measured at 
Ex/Em 558/583 nm. Data are the average ± SD of three cultures. c Plasmids were transformed into E. coli and cell‑free extracts analyzed by Western 
blotting; 10 µg protein were subjected to SDS‑PAGE, blotted onto PVDF membrane and visualized with anti‑DsRed antibody. Lane 1—E. coli (no 
plasmid); Lane 2—pRed1; Lane 3—pRedA1; Lane 4—pRedB1; Lane 5—pRedC1; Lanes 6 and 7—pBlazeC1; Lane 8—pBlazeC8; Lane 9—pBlazeC10. 
The arrow indicates the size of the DsRed protein
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coding region into the expression vector under the con-
trol of the constitutive hsp60 promoter (Fig. 2b).
In order to test this, we used PCR amplification to 
extend the region sequentially. We extended the gene 
to incorporate both additional start sites and generate 
proteins of 214, 220 and 225 amino acids. These vari-
ants were cloned into the same mycobacterial expression 
system and tested. Plasmids were transformed into M. 
tuberculosis and fluorescence was monitored. In contrast 
to mCherry, expression of a functional fluorescent DsRed 
was not seen with any truncated versions of the protein. 
In fact fluorescence could only be detected when the full 
length amino acid sequence (as annotated) was cloned 
into the expression vector; high level fluorescence was 
seen with transformants carrying the plasmid pBlazeC1 
(Fig. 2b).
We constructed two alternative vectors with DsRed 
under the control of either  PrpsA or  PG13 (pBlazeC8 and 
pBlazeC10 respectively); both of these constructs gave 
high level expression in M. tuberculosis. Western blotting 
using an anti-DsRed antibody in E. coli demonstrated 
that a protein of the expected size was only seen in bacte-
ria carrying the full length construct (pBlazeC series), but 
not in the strains carrying the truncated version (Fig. 2c; 
lanes 5–9). Two additional bands are see in the Western, 
these are unknown proteins, but are also present in the 
control E. coli (no plasmid, Fig. 2c, lane 1).
Discussion
We have determined that the functional translational 
start sites for two closely related FPs are different in M. 
tuberculosis. Although mCherry was functional even 
when a truncated version was being expressed, DsRed 
was non-functional in a truncated form and only fluo-
resced when expressed as a full length protein (225 
amino acids). Western blotting suggested that the lack 
of fluorescence was most likely due to a lack of protein 
expression, since proteins could not be detected in the 
plasmids carrying truncated forms. This difference may 
relate to protein stability, with the extended N-terminal 
portion of DsRed increasing stability or protein matura-
tion; alternatively this could be attributed to the physical 
state of the active proteins, since mCherry functions as a 
monomer, whereas DsRed is a tetramer which might also 
affect protein degradation.
Fluorescent proteins have proved useful in multiple 
applications in mycobacteria; our previous constructs 
using mCherry have been widely disseminated to the 
community and used in a range of methods. For example, 
we have used these for high throughput drug testing [16], 
and imaging infection using animal models [8]. Other 
approaches have used mCherry to develop reporter 
strains for environmental sensing [17].
In conclusion, we have codon-optimized DsRed for use 
in M. tuberculosis and demonstrated its high level fluo-
rescence in that species from three different promoters 
of slightly varying strength (hsp60, rpsA, and G13). These 
vectors extend our current repertoire of functional fluo-
rescent proteins for mycobacteria. They will be useful 
for generating fluorescent strains of M. tuberculosis for 
use in multiple studies, such as monitoring drug efficacy 
in vitro and in vivo [5, 8, 16, 18] and will allow for detec-
tion of multiple reporters simultaneously.
Limitations
• We have monitored the expression of DsRed under 
aerobic conditions only.
• We have not monitored long term stability of expres-
sion in the absence of antibiotic selection to maintain 
the plasmid.
• We have not monitored stability of expression 
in vivo.
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